Skip to content

Catherine Mazzacco

Catherine Mazzacco joined Servier’s Supervisory Board in March 2022.

Catherine is a seasoned international executive business leader in health care where she led companies and teams through significant strategic and operational transformations and has been instrumental in developing and launching major new therapies.

Catherine Mazzacco is currently a professional Board member.

She served Chief Executive Officer and President of LEO Pharma from 2019 to 2021. Prior to this role, Catherine Mazzacco was Senior Vice President, Global Commercial Operations, Life Sciences Division at GE HealthCare. Before joining GE HealthCare, Catherine Mazzacco spent over 25 years at Abbott Laboratories, where she held various global senior operational and strategic roles in Europe and in the US, including Vice President, Global Commercial Operations, Abbott Vision.

She currently also serves as a member of the board of directors of Krystal Biotech and Sight Sciences.

Catherine Mazzacco holds a Bachelor of Science in Engineering, Option Biotechnology from the University of Compi├Ęgne in France.